ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 8 filers reported holding ERYTECH PHARMA in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 625,000 | $13,125,000 | 1.33% |
| NEA Management Company, LLC | 625,000 | $13,125,000 | 0.58% |
| Baker Brothers Advisors | 3,090,069 | $64,891,000 | 0.55% |
| SPHERA FUNDS MANAGEMENT LTD. | 120,000 | $2,520,000 | 0.38% |
| Delek Group, Ltd. | 70,000 | $1,472,000 | 0.08% |
| MILLENNIUM MANAGEMENT LLC | 41,630 | $874,000 | 0.00% |
| UBS Group AG | 1,177 | $25,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 570 | $12,000 | 0.00% |